Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
Purpose: To accommodate the unprecedented number of critically ill patients with pneumonia caused by coronavirus disease 2019 (COVID-19) expansion of the capacity of intensive care unit (ICU) to clinical areas not previously used for critical care was necessary. We describe the global burden of COVID-19 admissions and the clinical and organizational characteristics associated with outcomes in critically ill COVID-19 patients. Methods: Multicenter, international, point prevalence study, including adult patients with SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) and a diagnosis of COVID-19 admitted to ICU between February 15th and May 15th, 2020. Results: 4994 patients from 280 ICUs in 46 countries were included. Included ICUs increased their total capacity from 4931 to 7630 beds, deploying personnel from other areas. Overall, 1986 (39.8%) patients were admitted to surge capacity beds. Invasive ventilation at admission was present in 2325 (46.5%) patients and was required during ICU stay in 85.8% of patients. 60-day mortality was 33.9% (IQR across units: 20%–50%) and ICU mortality 32.7%. Older age, invasive mechanical ventilation, and acute kidney injury (AKI) were associated with increased mortality. These associations were also confirmed specifically in mechanically ventilated patients. Admission to surge capacity beds was not associated with mortality, even after controlling for other factors. Conclusions: ICUs responded to the increase in COVID-19 patients by increasing bed availability and staff, admitting up to 40% of patients in surge capacity beds. Although mortality in this population was high, admission to a surge capacity bed was not associated with increased mortality. Older age, invasive mechanical ventilation, and AKI were identified as the strongest predictors of mortality.
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study
Greco M.;De Corte T.;Ercole A.;Antonelli M.;Azoulay E.;Citerio G.;Morris A. C.;De Pascale G.;Duska F.;Elbers P.;Einav S.;Forni L.;Galarza L.;Girbes A. R. J.;Grasselli G.;Gusarov V.;Jubb A.;Kesecioglu J.;Lavinio A.;Delgado M. C. M.;Mellinghoff J.;Myatra S. N.;Ostermann M.;Pellegrini M.;Povoa P.;Schaller S. J.;Teboul J. -L.;Wong A.;De Waele J. J.;Cecconi M.;Bezzi M.;Gira A.;Eller P.;Hamid T.;Haque I. U.;De Buyser W.;Cudia A.;De Backer D.;Foulon P.;Collin V.;De Waele J.;Van Hecke J.;De Waele E.;Van Malderen C.;Mesland J. -B.;Biston P.;Piagnerelli M.;Haentjens L.;De Schryver N.;Van Leemput J.;Vanhove P.;Bulpa P.;Ilieva V.;Katz D.;Binnie A.;Geagea A.;Tirapegui F.;Lago G.;Graf J.;Perez-Araos R.;Vargas P.;Martinez F.;Labarca E.;Franco D. M.;Parra-Tanoux D.;Reyes L. F.;Yepes D.;Peris F.;Stipic S. S.;Burgos C. V. C.;Boada P. R. N.;Brun J. L. B.;Ballesteros J. P. P.;Abdelnasser G.;Hammouda A.;Elmandouh O.;Azzam A.;Hussein A. M.;Galal I.;Awad A. K.;Azab M. A.;Abdalla M.;Assal H.;Alfishawy M.;Ghozy S.;Tharwat S.;Eldaly A.;Ellervee A.;Reinhard V.;Chrisment A.;Poyat C.;Badie J.;Ferrari F. B.;Weiss B.;Schellenberg C.;Grunow J. J.;Lorenz M.;Spieth P.;Bota M.;Fichtner F.;Lahmer K. F. T.;Meybohm J. H. P.;Vasileiadou N. M. G.;Chrysanthopoulou E.;Papamichalis P.;Soultati I.;Jog S.;Kalvit K.;Krupa I.;Tharwat A.;Nichol A.;McCarthy A.;Mahmoodpoor A.;Tonetti T.;Isoni P.;Spadaro S.;Volta C. A.;Mirabella L.;Noto A.;Florio G.;Guzzardella A.;Paleari C.;Baccanelli F.;Savi M.;Luca S.;Vaccarini B.;Montrucchio G.;Sales G.;Donadello K.;Gottin L.;Nizzero M.;Polati E.;De Rosa S.;Sulemanji D.;Abusalama A.;Elhadi M.;De FelipeJesus M.;Gonzalez D. R.;Robles V. H. M.;Canedo N.;Chavez A. E.;Dendane T.;Grady B.;de Jong B.;van der Heiden E.;Thoral P.;van den Bogaard B.;Spronk P. E.;Achterberg S.;Groeneveld M.;So R. K. L.;de Wijs C.;Scholten H.;Beishuizen A.;Cornet A. D.;Reidinga A. C.;Kranen H.;Mensink R.;Gasthuis S.;den Boer S.;de Groot M.;Beck O.;Bethlehem C.;van Bussel B.;Frenzel T.;de Jong C.;Wilting R.;Mehagnoul-Schipper J.;Alasia D.;Kumar A.;Qayyum A.;Rana M.;Jayyab M. A.;Sierra R. Q.;Hernandez A. M.;de Almeida J.;Taborda L.;Anselmo M.;Ramires T.;Silva C.;Roriz C.;Morais R.;Povoa P.;Patricio P.;Pinto A.;Santos M. L.;Costa V.;Cunha P.;Goncalves C.;Nunes S.;Camoes J.;Adriao D.;Oliveira A.;Omrani A.;Al Maslamani M.;elbuzidi A. S.;Al qudah B. M.;Akkari A. R.;Alkhatteb M.;Baiou A.;Husain A.;Alwraidat M.;Saif I. A.;Bakdach D.;Ahmed A.;Aleef M.;Bintaher A.;Petrisor C.;Popov E.;Popova K.;Dementienko M.;Teplykh B.;Pyregov A.;Davydova L.;Vladislav B.;Neporada E.;Zverev I.;Meshchaninova S.;Sokolov D.;Gavrilova E.;Shlyk I.;Poliakov I.;Vlasova M.;Aljuhani O.;Alkhalaf A.;Humaid F. B.;Arabi Y.;Kuhail A.;Elrabi O.;Ghannam M. E.;Fong N. T.;Kansal A.;Ho V. K.;Ng J.;Garcia R. R.;Fraga X. T.;del Pilar Garcia-Bonillo M.;Padilla-Serrano A.;Cuadrado M. M.;Ferrando C.;Catalan-Monzon I.;Frutos-Vivar F.;Jimenez J.;Rodriguez-Solis C.;Franquesa-Gonzalez E.;Acosta G. P.;Cabrera L. S.;Parra J. P. A.;Gonzalez F. M.;del Carmen Lorente Conesa M.;Varela I. Y. M.;Pravia O. V. B.;de Cabo C. M.;Ioan A. -M.;Perez-Calvo C.;Santos A.;Abad-Motos A.;Ripolles-Melchor J.;Martin B. C.;Teruel S. Y.;Lucas J. H.;Ortiz A. B.;de Pablo Sanchez R.;Barrueco-Francioni J. E.;Espina L. F.;Bonell-Goytisolo J. M.;Salaverria I.;Mir A. S.;Rodriguez-Ruiz E.;Valverde V. H.;Cubero P. J.;Linde F. A.;Leganes N. C.;Romeu J. M.;Concha P.;Berezo-Garcia J. A.;Fraile V.;Cuenca-Rubio C.;Perez-Torres D.;Serrano A.;Valero C. M.;Suner A. O.;Larranaga L.;Legaristi N.;Ferrigno G.;Khlafalla S.;Bihariesingh-Sanchit R.;Sjukhus H.;Zoerner F.;Grip J.;Kilsand K.;Martensson J.;Osterlind J.;Sjukhuset A.;von Seth M.;Sjukhus V.;Berkius J.;Ceruti S.;Glotta A.;Izdes S.;Turan I. O.;Cosar A.;Halacli B.;Dereli N.;Yilmaz M.;Akbas T.;Elay G.;Eyupoglu S.;Bilir Y.;Saracoglu K. T.;Kaya E.;Sahin A. S.;Ekren P. K.;Mengi T.;Suner K. O.;Tomak Y.;Eroglu A.;Alsabbah A.;Hanlon K.;Gervin K.;McMahon S.;Hagan S.;Higenbottam C. V.;Mullhi R.;Poulton L.;Torlinski T.;Gareth A.;Truman N.;Vijayakumar G.;Hall C.;Cagova L.;Jones N.;Graham S.;Robin N.;Cowton A.;Donnelly A.;Singatullina N.;Kent M.;Boulanger C.;Campbell Z.;Potter E.;Duric N.;Szakmany T.;Brompton R.;Kviatkovske O.;Marczin N.;Ellis C.;Saha R.;Sri-Chandana C.;Allan J.;Mumelj L.;Venkatesh H.;Gotz V. N.;Cochrane A.;Ficial B.;Kamble S.;Lumlertgul N.;Oddy C.;Jain S.;Crapelli G. B.;Vlachou A.;Golden D.;Garrioch S.;Henning J.;Loveleena G.;Davey M.;Grauslyte L.;Salciute-Simene E.;Cook M.;Barling D.;Broadhurst P.;Purvis S.;Spivey M.;Shuker B.;Grecu I.;Harding D.;Singatullina N.;Dean J. T.;Nielsen N. D.;Al-Bayati S.;Al-Sadawi M.;Charron M.;Stubenrauch P.;Santanilla J.;Wentowski C.;Rosenberger D.;Eksarko P.;Jawa R.
2022-01-01
Abstract
Purpose: To accommodate the unprecedented number of critically ill patients with pneumonia caused by coronavirus disease 2019 (COVID-19) expansion of the capacity of intensive care unit (ICU) to clinical areas not previously used for critical care was necessary. We describe the global burden of COVID-19 admissions and the clinical and organizational characteristics associated with outcomes in critically ill COVID-19 patients. Methods: Multicenter, international, point prevalence study, including adult patients with SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) and a diagnosis of COVID-19 admitted to ICU between February 15th and May 15th, 2020. Results: 4994 patients from 280 ICUs in 46 countries were included. Included ICUs increased their total capacity from 4931 to 7630 beds, deploying personnel from other areas. Overall, 1986 (39.8%) patients were admitted to surge capacity beds. Invasive ventilation at admission was present in 2325 (46.5%) patients and was required during ICU stay in 85.8% of patients. 60-day mortality was 33.9% (IQR across units: 20%–50%) and ICU mortality 32.7%. Older age, invasive mechanical ventilation, and acute kidney injury (AKI) were associated with increased mortality. These associations were also confirmed specifically in mechanically ventilated patients. Admission to surge capacity beds was not associated with mortality, even after controlling for other factors. Conclusions: ICUs responded to the increase in COVID-19 patients by increasing bed availability and staff, admitting up to 40% of patients in surge capacity beds. Although mortality in this population was high, admission to a surge capacity bed was not associated with increased mortality. Older age, invasive mechanical ventilation, and AKI were identified as the strongest predictors of mortality.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/1345985
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
ND
ND
60
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.